Log In
BCIQ
Print this Print this
 

Egalet-003

  Manage Alerts
Collapse Summary General Information
Company Egalet Corp.
DescriptionAbuse-deterrent opioid
Molecular Target Opioid receptor (OPR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today